Pekin, Singer Strauss Asset Management »

Galectin Therapeutics shares owned by Pekin, Singer Strauss Asset Management

Quarter-by-quarter ownership of Galectin Therapeutics (GALT) shares owned by Pekin, Singer Strauss Asset Management from 13F filings

Historical chart of Pekin, Singer Strauss Asset Management investment in Galectin Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Galectin Therapeutics held by Pekin, Singer Strauss Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Galectin Therapeutics by Pekin, Singer Strauss Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $84k 30k 2.79

More positions owned by Pekin, Singer Strauss Asset Management

Cameco Corporation (CCJ)
Simplify Exchange Traded Fun Mbs Etf (MTBA)
Exxon Mobil Corporation (XOM)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Ishares Msci Brazil Etf (EWZ)
Apple (AAPL)
SM Energy (SM)
Vaneck Etf Trust Gold Miners Etf (GDX)
Ishares Msci Sth Kor Etf (EWY)
Alphabet Cap Stk Cl A (GOOGL)
Vaneck Merk Gold Etf Gold Shs (OUNZ)
Lyondellbasell Industries Nv Shs - A - (LYB)
Alphabet Cap Stk Cl C (GOOG)
Vaneck Etf Trust Jp Mrgan Em Loc (EMLC)
Devon Energy Corporation (DVN)

View all positions for Pekin, Singer Strauss Asset Management

Top funds holding Galectin Therapeutics

Vanguard Group
Vanguard Capital Management
Advisor Group Holdings
Susquehanna International
Dr. Jeffrey R. Jay, M.D.
BlackRock
Millennium Management
Sontag Advisory
Geode Capital Management
Marshall Wace
Two Sigma Investments
Commonwealth Equity Services
Citadel Advisors
Jane Street
Vanguard Fiduciary Trust

View all funds holding Galectin Therapeutics